{"id":47286,"date":"2024-12-20T11:01:12","date_gmt":"2024-12-20T11:01:12","guid":{"rendered":"https:\/\/ibima.eu\/miguel-angel-berciano-guerrero\/"},"modified":"2026-01-05T12:33:31","modified_gmt":"2026-01-05T12:33:31","slug":"miguel-angel-berciano-guerrero","status":"publish","type":"post","link":"https:\/\/ibima.eu\/en\/miguel-angel-berciano-guerrero\/","title":{"rendered":"MIGUEL \u00c1NGEL BERCIANO GUERRERO"},"content":{"rendered":"<p>Research profile: R4<\/p>\n<h4 data-start=\"312\" data-end=\"704\"><strong data-start=\"312\" data-end=\"353\"><span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Miguel \u00c1ngel Berciano Guerrero<\/span><\/span><\/strong> es Investigador Responsable del <strong data-start=\"386\" data-end=\"448\">grupo BE-23 \u201cNuevos Horizontes para Pacientes Oncol\u00f3gicos\u201d<\/strong> del Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga \u2013 IBIMA<br data-start=\"507\" data-end=\"510\" \/>(<a class=\"decorated-link\" href=\"https:\/\/ibima.eu\/en\/project\/be-23\/?utm_source=chatgpt.com\" target=\"_new\" rel=\"noopener\" data-start=\"511\" data-end=\"545\">https:\/\/ibima.eu\/es\/project\/be-23\/<\/a>). Desarrolla investigaci\u00f3n traslacional y cl\u00ednica en oncolog\u00eda m\u00e9dica aplicada a tumores s\u00f3lidos y terapias innovadoras.<\/h4>\n<p data-start=\"706\" data-end=\"1029\">Es m\u00e9dico especialista en Oncolog\u00eda M\u00e9dica con amplia experiencia asistencial, docente e investigadora en c\u00e1ncer. Desarrolla su actividad principal en el <span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">University Regional Hospital of M\u00e1laga<\/span><\/span>, donde participa en m\u00faltiples ensayos cl\u00ednicos y estudios de nuevas estrategias terap\u00e9uticas.<\/p>\n<p data-start=\"1031\" data-end=\"1424\">Su trabajo cient\u00edfico se centra en la <strong data-start=\"1069\" data-end=\"1109\">investigaci\u00f3n traslacional en c\u00e1ncer<\/strong>, el desarrollo de <strong data-start=\"1128\" data-end=\"1158\">nuevos f\u00e1rmacos y terapias<\/strong>, la <strong data-start=\"1163\" data-end=\"1201\">terapia celular en tumores s\u00f3lidos<\/strong> y el estudio del <strong data-start=\"1219\" data-end=\"1244\">microambiente tumoral<\/strong>. Lidera proyectos colaborativos y estrategias multidisciplinares para mejorar la atenci\u00f3n y los resultados cl\u00ednicos de pacientes oncol\u00f3gicos.<\/p>\n<p data-start=\"1426\" data-end=\"1781\">Ha participado como investigador en numerosos <strong data-start=\"1472\" data-end=\"1507\">ensayos cl\u00ednicos multic\u00e9ntricos<\/strong> en diferentes fases, tanto en tumores melanoma como en otras neoplasias s\u00f3lidas. Entre ellos se incluyen estudios de inmunoterapia y terapias innovadoras con agentes inmunomoduladores y anticuerpos contra puntos de control inmunitario.<\/p>\n<p data-start=\"2038\" data-end=\"2092\"><strong data-start=\"2038\" data-end=\"2051\">Contact:<\/strong> <a class=\"decorated-link cursor-pointer\" rel=\"noopener\" data-start=\"2052\" data-end=\"2092\">mangel.berciano.sspa@juntadeandalucia.es<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Perfil investigador\/a: R4 Miguel \u00c1ngel Berciano Guerrero es Investigador Responsable del grupo BE-23 \u201cNuevos Horizontes para Pacientes Oncol\u00f3gicos\u201d del Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga \u2013 IBIMA(https:\/\/ibima.eu\/es\/project\/be-23\/). Desarrolla investigaci\u00f3n traslacional y cl\u00ednica en oncolog\u00eda m\u00e9dica aplicada a tumores s\u00f3lidos y terapias innovadoras. Es m\u00e9dico especialista en Oncolog\u00eda M\u00e9dica con amplia experiencia asistencial, docente e investigadora [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":49730,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2642],"tags":[3117,2747,2230,2103,3115],"class_list":["post-47286","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-investigador-responsable-be-23","tag-horizontes","tag-ibima","tag-investigacion","tag-oncologia","tag-pacientes-oncologicos"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MIGUEL \u00c1NGEL BERCIANO GUERRERO - Ibima<\/title>\n<meta name=\"description\" content=\"Miguel \u00c1ngel Berciano Guerrero es investigador responsable del grupo de IBIMA nuevos horizontes para pacientes oncol\u00f3gicos (BE-23)\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibima.eu\/en\/miguel-angel-berciano-guerrero\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MIGUEL \u00c1NGEL BERCIANO GUERRERO - Ibima\" \/>\n<meta property=\"og:description\" content=\"Miguel \u00c1ngel Berciano Guerrero es investigador responsable del grupo de IBIMA nuevos horizontes para pacientes oncol\u00f3gicos (BE-23)\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibima.eu\/en\/miguel-angel-berciano-guerrero\/\" \/>\n<meta property=\"og:site_name\" content=\"Ibima\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-20T11:01:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-05T12:33:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/12\/Miguel-Angel-Berciano.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1461\" \/>\n\t<meta property=\"og:image:height\" content=\"1510\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"prodriguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"prodriguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/miguel-angel-berciano-guerrero\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/miguel-angel-berciano-guerrero\\\/\"},\"author\":{\"name\":\"prodriguez\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"headline\":\"MIGUEL \u00c1NGEL BERCIANO GUERRERO\",\"datePublished\":\"2024-12-20T11:01:12+00:00\",\"dateModified\":\"2026-01-05T12:33:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/miguel-angel-berciano-guerrero\\\/\"},\"wordCount\":212,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/miguel-angel-berciano-guerrero\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/Miguel-Angel-Berciano.jpeg\",\"keywords\":[\"horizontes\",\"IBIMA\",\"Investigacion\",\"oncolog\u00eda\",\"pacientes oncologicos\"],\"articleSection\":[\"Investigador Responsable - BE-23\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/miguel-angel-berciano-guerrero\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/miguel-angel-berciano-guerrero\\\/\",\"url\":\"https:\\\/\\\/ibima.eu\\\/miguel-angel-berciano-guerrero\\\/\",\"name\":\"MIGUEL \u00c1NGEL BERCIANO GUERRERO - Ibima\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/miguel-angel-berciano-guerrero\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/miguel-angel-berciano-guerrero\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/Miguel-Angel-Berciano.jpeg\",\"datePublished\":\"2024-12-20T11:01:12+00:00\",\"dateModified\":\"2026-01-05T12:33:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\"},\"description\":\"Miguel \u00c1ngel Berciano Guerrero es investigador responsable del grupo de IBIMA nuevos horizontes para pacientes oncol\u00f3gicos (BE-23)\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/miguel-angel-berciano-guerrero\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/miguel-angel-berciano-guerrero\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/miguel-angel-berciano-guerrero\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/Miguel-Angel-Berciano.jpeg\",\"contentUrl\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/Miguel-Angel-Berciano.jpeg\",\"width\":1461,\"height\":1510,\"caption\":\"Miguel \u00c1ngel Berciano\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/miguel-angel-berciano-guerrero\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MIGUEL \u00c1NGEL BERCIANO GUERRERO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\",\"name\":\"Ibima\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibima.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/40b410344dd5ad2315bb651e3fbfa635\",\"name\":\"prodriguez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g\",\"caption\":\"prodriguez\"},\"sameAs\":[\"https:\\\/\\\/ibima.eu\"],\"url\":\"https:\\\/\\\/ibima.eu\\\/en\\\/author\\\/prodriguez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MIGUEL \u00c1NGEL BERCIANO GUERRERO - Ibima","description":"Miguel \u00c1ngel Berciano Guerrero es investigador responsable del grupo de IBIMA nuevos horizontes para pacientes oncol\u00f3gicos (BE-23)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibima.eu\/en\/miguel-angel-berciano-guerrero\/","og_locale":"en_GB","og_type":"article","og_title":"MIGUEL \u00c1NGEL BERCIANO GUERRERO - Ibima","og_description":"Miguel \u00c1ngel Berciano Guerrero es investigador responsable del grupo de IBIMA nuevos horizontes para pacientes oncol\u00f3gicos (BE-23)","og_url":"https:\/\/ibima.eu\/en\/miguel-angel-berciano-guerrero\/","og_site_name":"Ibima","article_published_time":"2024-12-20T11:01:12+00:00","article_modified_time":"2026-01-05T12:33:31+00:00","og_image":[{"width":1461,"height":1510,"url":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/12\/Miguel-Angel-Berciano.jpeg","type":"image\/jpeg"}],"author":"prodriguez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"prodriguez","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ibima.eu\/miguel-angel-berciano-guerrero\/#article","isPartOf":{"@id":"https:\/\/ibima.eu\/miguel-angel-berciano-guerrero\/"},"author":{"name":"prodriguez","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"headline":"MIGUEL \u00c1NGEL BERCIANO GUERRERO","datePublished":"2024-12-20T11:01:12+00:00","dateModified":"2026-01-05T12:33:31+00:00","mainEntityOfPage":{"@id":"https:\/\/ibima.eu\/miguel-angel-berciano-guerrero\/"},"wordCount":212,"commentCount":0,"image":{"@id":"https:\/\/ibima.eu\/miguel-angel-berciano-guerrero\/#primaryimage"},"thumbnailUrl":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/12\/Miguel-Angel-Berciano.jpeg","keywords":["horizontes","IBIMA","Investigacion","oncolog\u00eda","pacientes oncologicos"],"articleSection":["Investigador Responsable - BE-23"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ibima.eu\/miguel-angel-berciano-guerrero\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ibima.eu\/miguel-angel-berciano-guerrero\/","url":"https:\/\/ibima.eu\/miguel-angel-berciano-guerrero\/","name":"MIGUEL \u00c1NGEL BERCIANO GUERRERO - Ibima","isPartOf":{"@id":"https:\/\/ibima.eu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ibima.eu\/miguel-angel-berciano-guerrero\/#primaryimage"},"image":{"@id":"https:\/\/ibima.eu\/miguel-angel-berciano-guerrero\/#primaryimage"},"thumbnailUrl":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/12\/Miguel-Angel-Berciano.jpeg","datePublished":"2024-12-20T11:01:12+00:00","dateModified":"2026-01-05T12:33:31+00:00","author":{"@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"description":"Miguel \u00c1ngel Berciano Guerrero es investigador responsable del grupo de IBIMA nuevos horizontes para pacientes oncol\u00f3gicos (BE-23)","breadcrumb":{"@id":"https:\/\/ibima.eu\/miguel-angel-berciano-guerrero\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibima.eu\/miguel-angel-berciano-guerrero\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ibima.eu\/miguel-angel-berciano-guerrero\/#primaryimage","url":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/12\/Miguel-Angel-Berciano.jpeg","contentUrl":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/12\/Miguel-Angel-Berciano.jpeg","width":1461,"height":1510,"caption":"Miguel \u00c1ngel Berciano"},{"@type":"BreadcrumbList","@id":"https:\/\/ibima.eu\/miguel-angel-berciano-guerrero\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibima.eu\/es\/"},{"@type":"ListItem","position":2,"name":"MIGUEL \u00c1NGEL BERCIANO GUERRERO"}]},{"@type":"WebSite","@id":"https:\/\/ibima.eu\/es\/#website","url":"https:\/\/ibima.eu\/es\/","name":"Ibima","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibima.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635","name":"prodriguez","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3e682b55f425f54644efd95284b890bfd6e129cc61dd791a9d4345ce1ed26791?s=96&d=mm&r=g","caption":"prodriguez"},"sameAs":["https:\/\/ibima.eu"],"url":"https:\/\/ibima.eu\/en\/author\/prodriguez\/"}]}},"_links":{"self":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/47286","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/comments?post=47286"}],"version-history":[{"count":3,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/47286\/revisions"}],"predecessor-version":[{"id":59238,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/47286\/revisions\/59238"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/media\/49730"}],"wp:attachment":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/media?parent=47286"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/categories?post=47286"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/tags?post=47286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}